Journal of Gastroenterology

, Volume 45, Issue 4, pp 355–369 | Cite as

Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis

  • Shigeyuki Kawa
  • Kazuichi Okazaki
  • Terumi Kamisawa
  • Toru Shimosegawa
  • Masao Tanaka
  • Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society
Review

References

  1. 1.
    Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52:683–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas. 2003;27:20–5.CrossRefPubMedGoogle Scholar
  3. 3.
    Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999;354:43–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:625–30.PubMedGoogle Scholar
  5. 5.
    Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474–6.CrossRefPubMedGoogle Scholar
  7. 7.
    van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med. 2004;141:896–7.PubMedGoogle Scholar
  8. 8.
    Komatsu K, Hamano H, Ochi Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005;50:1052–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Yoshimura Y, Takeda S, Ieki Y, et al. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med. 2006;45:897–901.CrossRefPubMedGoogle Scholar
  10. 10.
    Okazaki K, Uchida K, Matsushita M, et al. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol. 2007;42(Suppl 18):32–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31:232–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197–205.CrossRefPubMedGoogle Scholar
  13. 13.
    Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas. 2003;27:235–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz’s disease. Scand J Rheumatol. 2004;33:432–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz’s disease and Sjogren’s syndrome. Rheumatology (Oxford). 2005;44:227–34.CrossRefGoogle Scholar
  16. 16.
    Manoussakis M, Mouttsopoulos H. Sjoegren syndrome. 4th ed. St Louis: Academic Press; 2006.Google Scholar
  17. 17.
    Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut. 2004;53:770. (author reply 770–1).PubMedGoogle Scholar
  18. 18.
    Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36:58–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med. 2008;47:291–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Hamed G, Tsushima K, Yasuo M, et al. Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology. 2007;12:455–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.CrossRefPubMedGoogle Scholar
  23. 23.
    Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20–5.PubMedGoogle Scholar
  24. 24.
    Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol. 2007;42:550–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.PubMedGoogle Scholar
  26. 26.
    Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.CrossRefPubMedGoogle Scholar
  27. 27.
    Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.CrossRefPubMedGoogle Scholar
  28. 28.
    Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients’ sera. Histopathology. 2005;47:147–58.CrossRefPubMedGoogle Scholar
  29. 29.
    Uehara T, Hamano H, Kawa S, et al. Distinct clinicopathological entity ‘autoimmune pancreatitis-associated sclerosing cholangitis’. Pathol Int. 2005;55:405–11.CrossRefPubMedGoogle Scholar
  30. 30.
    Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46:463–71.CrossRefPubMedGoogle Scholar
  31. 31.
    Hamano H, Umemura T, Uehara T, et al. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691–2.CrossRefPubMedGoogle Scholar
  32. 32.
    Hayashi K, Nakazawa T, Ohara H, et al. Autoimmune sclerosing cholangiopancreatitis with little pancreatic involvements by imaging findings. Hepatogastroenterology. 2007;54:2146–51.PubMedGoogle Scholar
  33. 33.
    Tamada K, Kanai N, Wada S. Utility and limitations of intraductal ultrasonography in distinguishing longitudinal cancer extension along the bile duct from inflammatory wall thickening. Abdom Imaging. 2001;26:623–31.CrossRefPubMedGoogle Scholar
  34. 34.
    Kitajima Y, Ohara H, Nakazawa T. Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J Gastroenterol Hepatol. 2007;22:1615–20.CrossRefPubMedGoogle Scholar
  35. 35.
    Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol. 2003;38:1155–61.CrossRefPubMedGoogle Scholar
  36. 36.
    Hyodo T, Hyodo N, Yamanaka T. Contrast-enhanced intraductal ultrasonography for thickened bile duct wall. J Gastroenterol. 2001;36:557–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Tamada K, Tomiyama T, Oohashi A, et al. Bile duct wall thickness measured by intraductal US in patients who have not undergone previous biliary drainage. Gastrointest Endosc. 1999;48:199–203.CrossRefGoogle Scholar
  38. 38.
    Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am J Surg Pathol. 2003;27:110–20.CrossRefPubMedGoogle Scholar
  39. 39.
    Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51:1–4.CrossRefPubMedGoogle Scholar
  41. 41.
    Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.CrossRefPubMedGoogle Scholar
  42. 42.
    Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Kawa S, Hamano H, Kiyosawa K. Pancreatitis. 4th ed. St Louis: Academic Press; 2006.Google Scholar
  44. 44.
    Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol. 2007;42(Suppl 18):9–14.CrossRefPubMedGoogle Scholar
  45. 45.
    Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646–53.CrossRefPubMedGoogle Scholar
  46. 46.
    Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas. 2007;35:156–61.CrossRefPubMedGoogle Scholar
  47. 47.
    Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. Am J Roentgenol. 1998;170:1323–7.Google Scholar
  48. 48.
    Takahashi N, Fletcher JG, Fidler JL, et al. Dual-phase CT of autoimmune pancreatitis: a multireader study. Am J Roentgenol. 2008;190:280–6.CrossRefGoogle Scholar
  49. 49.
    Kawamoto S, Siegelman SS, Hruban RH, et al. Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics. 2008;28:157–70.CrossRefPubMedGoogle Scholar
  50. 50.
    Ichikawa T, Sou H, Araki T. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107–16.CrossRefPubMedGoogle Scholar
  51. 51.
    Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Farrell JJ, Garber J, Sahani D, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc. 2004;60:927–36.CrossRefPubMedGoogle Scholar
  53. 53.
    Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345–52.CrossRefPubMedGoogle Scholar
  54. 54.
    Kamisawa T, Egawa N, Nakajima H, et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98:2694–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Sahai A, Zimmerman M, Aabakken L, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 1998;48:18–25.CrossRefPubMedGoogle Scholar
  56. 56.
    Rösch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc. 1991;37:347–52.CrossRefPubMedGoogle Scholar
  57. 57.
    Deshpande V, Mino-Kenudson M, Brugge WR, et al. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol. 2005;29:1464–71.CrossRefPubMedGoogle Scholar
  58. 58.
    Williams D, Sahai A, Aabakken L, et al. Endoscopic ultrasound guided fine-needle aspiration biopsy: a large single centre experience. GUT. 1999;44:720–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Eloubeidi M, Chen V, Eltoum I. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663–8.PubMedGoogle Scholar
  60. 60.
    Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 2006;33:208–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008;39:1548–51.CrossRefPubMedGoogle Scholar
  62. 62.
    Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMedGoogle Scholar
  63. 63.
    Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23–8.CrossRefPubMedGoogle Scholar
  64. 64.
    Bang SJ, Kim MH, Kim do H, et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas. 2008;36:84–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Shigeyuki Kawa
    • 1
  • Kazuichi Okazaki
    • 2
  • Terumi Kamisawa
    • 3
  • Toru Shimosegawa
    • 4
  • Masao Tanaka
    • 5
  • Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society
  1. 1.Center for Health, Safety and Environmental ManagementShinshu UniversityMatsumotoJapan
  2. 2.Department of Gastroenterology and HepatologyKansai Medical UniversityOsakaJapan
  3. 3.Department of Internal MedicineTokyo Metropolitan Komagome HospitalTokyoJapan
  4. 4.Division of GastroenterologyTohoku University Graduate School of MedicineSendaiJapan
  5. 5.Department of Surgery and Oncology, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations